Alaska Air Group ALK is expanding its network by introducing new routes as it offers the largest summer schedule in its ...

In the latest trading session, Alaska Air Group (ALK) closed at $41.45, marking a -0.74% move from the previous day.

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the Board of Directors has adopted a new corporate strategy (Allergy +) and 2028 financial ambitions. Allergy + aims to further strengthen ALK’s ...

Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 3 CROWN trial evaluating LORBRENA ® ...

Researchers believe the drug could make certain kinds of lung cancers a chronic disease like diabetes, and not necessarily a ...

A video has been posted on Instagram with the claim that it shows a Singapore Airlines flight from the UK capital London to ...

A large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is ...

Pfizer has shared positive longer-term follow-up results from a late-stage study of its anaplastic lymphoma kinase (ALK) ...

Five-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some ...

On May 16, 2024, the FDA granted a breakthrough therapy designation to NVL-655, a novel brain-penetrant ALK-selective ...

With five years of follow-up, first-line lorlatinib reduced the risk of disease progression or death as well as progression ...